New Key Statistics Module, Z-Score and F-Score
OTCPK:MEDXF Key Ratios
| Market Cap $ M | 37.62 |
| Enterprise Value $ M | 72.91 |
| P/E(ttm) | 30.18 |
| PE Ratio without NRI | 28.47 |
| Forward PE Ratio | 23.22 |
| Price/Book | 1.17 |
| Price/Sales | 0.33 |
| Price/Free Cash Flow | 1.57 |
| Price/Owner Earnings | 3.62 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 108.00 |
| EPS (TTM) $ | 0.05 |
| Beneish M-Score | -3.51 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -11.30 |
| EV-to-EBIT | 5.95 |
| EV-to-EBITDA | 4.04 |
| PEG | -- |
| Shares Outstanding M | 24.53 |
| Net Margin (%) | 1.03 |
| Operating Margin % | 11.31 |
| Pre-tax Margin (%) | 1.06 |
| Quick Ratio | 0.49 |
| Current Ratio | 1.10 |
| ROA % (ttm) | 0.71 |
| ROE % (ttm) | 4.10 |
| ROIC % (ttm) | 10.28 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.64 |
MEDXF Number of Guru Trades
MEDXF Volume of Guru Trades
Gurus Latest Trades with OTCPK:MEDXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:MEDXF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Medexus Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:MEDXF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers